Annexon Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 27, 2023

https://www.globenewswire.com/news-release/2023/12/27/2801303/0/en/Annexon-Biosciences-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html

BRISBANE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq:ANNX) a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that Douglas Love, president and chief executive officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 2:15 p.m. PT in San Francisco.

Read more at globenewswire.com

Related news for (ANNX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.